ARHCF(ARHCF)
ARHCF
No analyst ratings available
No analyst price targets available for ARHCF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.24T | $3.31T | $3.38T | $3.47T | $3.55T |
| Low | $3.22T | $3.29T | $3.36T | $3.44T | $3.53T |
| High | $3.26T | $3.33T | $3.40T | $3.48T | $3.57T |
| EBITDA Avg | $63.42B | $64.88B | $66.25B | $67.83B | $69.47B |
| Low | $63.07B | $64.37B | $65.81B | $67.38B | $69.01B |
| High | $63.73B | $65.23B | $66.59B | $68.18B | $69.83B |
| EBIT Avg | $47.54B | $48.63B | $49.66B | $50.85B | $52.07B |
| Low | $47.28B | $48.25B | $49.33B | $50.50B | $51.72B |
| High | $47.77B | $48.89B | $49.92B | $51.10B | $52.34B |
| Net Income Avg | $24.15B | $26.07B | $27.74B | $29.32B | $30.97B |
| Low | $23.94B | $25.84B | $27.50B | $29.06B | $30.70B |
| High | $24.31B | $26.24B | $27.92B | $29.51B | $31.17B |
| EPS Avg | $132.84 | $143.39 | $152.59 | $161.27 | $170.36 |
| Low | $131.68 | $142.14 | $151.25 | $159.87 | $168.87 |
| High | $133.72 | $144.34 | $153.60 | $162.34 | $171.49 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $795.79B | $867.91B | $781.66B |
| Low | $788.61B | $862.50B | $775.74B |
| High | $802.98B | $873.31B | $787.58B |
| EBITDA Avg | $15.58B | $16.99B | $15.30B |
| Low | $15.44B | $16.88B | $15.18B |
| High | $15.72B | $17.09B | $15.42B |
| EBIT Avg | $11.68B | $12.73B | $11.47B |
| Low | $11.57B | $12.65B | $11.38B |
| High | $11.78B | $12.81B | $11.56B |
| Net Income Avg | $5.43B | $20.32B | $4.65B |
| Low | $5.37B | $20.12B | $4.60B |
| High | $5.48B | $20.53B | $4.69B |
| EPS Avg | $30.34 | $113.67 | $25.98 |
| Low | $30.04 | $112.55 | $25.73 |
| High | $30.64 | $114.79 | $26.24 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |